País: Austrália
Língua: inglês
Origem: APVMA (Australian Pesticides and Veterinary Medicines Authority)
AMPICILLIN AS THE SODIUM SALT; CLOXACILLIN AS SODIUM MONOHYDRATE SALT
NORBROOK LABORATORIES AUSTRALIA PTY LIMITED
cloxacillin as Na salt(200mg/Sg)+ampicillin as Na salt(75mg/Sg)
MISC. INTRA MAMMARY
AMPICILLIN AS THE SODIUM SALT ANTIBIOTIC Active 75.0 mg/5gsyr; CLOXACILLIN AS SODIUM MONOHYDRATE SALT ANTIBIOTIC Active 200.0 mg/5gsyr
20 x 5g; Syringe
VM - Veterinary Medicine
DAIRY CATTLE LACTATING | BOVINE | MILKING COW
ANTIBIOTIC & RELATED
ANTIBIOTIC - ANTI-INFECTIVE | ANTIBIOTICS - ORAL, PARENTERAL | ARCANOBACTERIUM SPP. | BACTERIAL INFECTION | CORYNEBACTERIUM SPP. | ESCHERICHIA COLI (E. COLI) | MASTITIS | ORGANISMS SENSITIVE TO CLOXACILLIN | STAPHYLOCOCCUS SPP. | STREPTOCOCCUS AGALACTIAE | STREPTOCOCCUS SPP. | ABRASIONS | ABSCESSES | AIRSACCULITIS | AMOXYCILLIN SENSITIVE BACTERIA | ANAEROBIC BACTERIAL INFECTION | ANTISEPTIC | ASSOCIATED WITH VIRAL DISEASE | AVIAN MYCOPLASMAS | BACTERIAL CANKER | BLACKHEAD | BODY ODOURS | BOWED TENDONS | BROAD SPECTRUM | BURNS | CLAVULANIC ACID SENSITIVE | COCCIDIOSIS | COLIFORM COMPLEX | CONJUNCTIVITIS | CORYZA | COWPOX | CRACKS | CRD | CRUSTS | DANDRUFF | DERMATOLOGICAL DISORDERS | DERMATOSES | DERMATOSIS | DIARRHOEA | DRY SKIN | DYSENTERY | ECZEMA | ENDOMETRITIS | ENTERIC DISEASES | ENTERITIS | ENZOOTIC PNEUMONIA | ESCHERICHIA COLI | EUROPEAN BROOD DISEASE | FEED EFFICIENCY | FUNGAL INFECTIONS | GENTAMICIN SENSITIVE | GIRTH GALLS | GRAM NEGATIVE ORGANISMS | GRAM POSITIVE ORGANISMS | HYPERMOTILITY | INCLUDIN
Poison schedule: 4; Withholding period: WHP: Meat: Do not use less than 30 days before slaughter for human consumption . Milk: Milk collected from cows within 72 hours (6 milkings) following treat ment must not be used for human consump tion or processing or be fed to bobby calves. TRADE ADVICE: EXPORT SLAUGHTER INTERVAL (ESI) This product does not h ave an ESI established. For advice on t he ESI contact the manufacturer on 1800 665 866 before using this product.; Host/pest details: DAIRY CATTLE LACTATING: [ANTIBIOTIC - ANTI-INFECTIVE, ANTIBIOTICS - ORAL, PARENTERAL, ARCANOBACTERIUM SPP., BACTERIAL INFECTION, CORYNEBACTERIUM SPP., ESCHERICHIA COLI (E. COLI), MASTITIS, ORGANISMS SENSITIVE TO CLOXACILLIN, STAPHYLOCOCCUS SPP., STREPTOCOCCUS AGALACTIAE, STREPTOCOCCUS SPP.]; Poison schedule: 4; Withholding period: ; Host/pest details: DAIRY CATTLE LACTATING: [ANTIBIOTIC - ANTI-INFECTIVE, ANTIBIOTICS - ORAL, PARENTERAL, ARCANOBACTERIUM SPP., BACTERIAL INFECTION, CORYNEBACTERIUM SPP., ESCHERICHIA COLI (E. COLI), MASTITIS, ORGANISMS SENSITIVE TO CLOXACILLIN, STAPHYLOCOCCUS SPP., STREPTOCOCCUS AGALACTIAE, STREPTOCOCCUS SPP.]; For the treatment of mastitis in lactating dairy cows caused by organisms susceptible to cloxacillin and ampicillin.Milk collected from cows within 72 hrs (6 milkings) following treatment MUST NOT BE USED for human consumption or processing, or be fed to bobby calves.
Stopped
2021-07-01
_LL_ _£ _ 11111111 Norbrooll ~ Lactaclox LC 20 x 5g Carton Label file name: 56113_48094_20_primary_MPL_V1.pdf 100% Actual1 :1 Size= 175 x 92 x 148 mm (73% when printed on A3 paper 50% when printed on A4 paper) 21/9/09 Norbrooll ~ ® Expiry: APPROVED LABEL Info PEST Verified LACTACLOX LC 5G SYRINGE LABEL LABEL FILE NAME: 56113_ 48094_IMMEDIATE_MPL_ V1.PDF 100% ACTUAL 1:1 SIZE= 57.6 X 47.6MM (100% WHEN PRINTED ON A4 PAPER) 21/9/09 RfAI) ENCI.OSm LEAfLET BEI'OAE USIIG THIS .. mr.r DIRECTIONS FOR USE: Infuse 1lle contants quarter MfY 12 hours for 3 tnl8lments. W!THII()U)tjG F'ERJOOS: MLK- 12 hOcn (8 ml l ldngtl; MEAT -30 dlys Store below 25'C (Air cood~. @ Ptctect ftoollighl. B Af'IIW.No: 5611:!12Ml8W Elqr. Distributed by: NOitrook l.aboralories Allstralia Pty lirited APPROVED LABEL Info PEST Verified LACTACLOX LC LEAFLET - PAGE 1 OF 2 LABEL FILE NAME: 56113_48094_1EAFLET_MPL_V1.PDF 100% ACTUAL1:1 SIZE= 105 X 148MM (100% WHEN PRINTED ON A4 PAPER) 21/9/09 PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY LACTACLOX LC LACTATING COW LNTRAMAMMARY ANTIBIOTIC INFUSION PRODUCT DESCRIPTION LACTACLOX LC Lactating Cow lntramammary Antibiotic Infusion is a stable intramammary suspension prepared under sterile conditions. Each 5 g syringe contains 200 mg CLOXACILLIN (as sodium monohydrate salt) and 75 mg AMPICILLIN (as the sodium salt) in a quick-release base. INDICATIONS LACTACLOX LC Lactating Cow lntramammary Antibiotic Infusion is a broad spectrum antibiotic preparation which is indicated for the early treatment of bovine mastitis caused by Streptococcus spp., Staphylococcus spp. Oncluding penicillin resistant strains), Arcanobacterium (Corynebacterium) spp. and other organisms susceptible to cloxacillin and ampicillin. LACTACLOX LC Lactating Cow lntramammary Antibiotic Infusion is indicated for the treatment of mastitis in lactating cows caused by organisms sensitive to cloxacillin and ampicillin. It is particularly recommended where the causative organisms have not been identified and w Leia o documento completo
PRODUCT NAME: LACTACLOX LACTATING COW INTRAMAMMARY ANTIBIOTIC INFUSION PAGE: 1 OF 4 THIS REVISION ISSUED: SEPTEMBER, 2009 MATERIAL SAFETY DATA SHEET Issued by: Norbrook Laboratories Australia Pty Ltd Freecall: 1800 665 866 POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800 764 766 IN NEW ZEALAND) SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY NORBROOK LABORATORIES AUSTRALIA PTY LTD FREECALL: 1800 665 866 UNIT 7/1 TRADE PARK DRIVE TULLAMARINE, VIC 3043 AUSTRALIA SUBSTANCE: Ampicillin and Cloxacillin are semi-synthetic penicillins derived from 6-amino- penicillanic acid. TRADE NAME: LACTACLOX LC LACTATING COW INTRAMAMMARY ANTIBIOTIC INFUSION APVMA CODE: 56113 PRODUCT USE: For the treatment of mastitis in dairy cows caused by organisms sensitive to ampicillin and cloxacillin. CREATION DATE: SEPTEMBER, 2009 THIS VERSION ISSUED: SEPTEMBER, 2009 and is valid for 5 years from this date. SECTION 2 - HAZARDS IDENTIFICATION STATEMENT OF HAZARDOUS NATURE This product is classified as: Not classified as hazardous according to the criteria of SWA. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: S36, S24/25. Wear suitable protective clothing. Avoid contact with skin and eyes. SUSDP CLASSIFICATION: S4 ADG CLASSIFICATION: None allocated. Not a Dangerous Good under the ADG Code. UN NUMBER: None allocated EMERGENCY OVERVIEW PHYSICAL DESCRIPTION & COLOUR : Off-white to creamy liquid suspension. ODOUR: Virtually odourless. MAJOR HEALTH HAZARDS: This is an antibiotic preparation. Any person with a history of allergies to this class of substances should avoid all contact with this product as it may cause sensitisation. This is a physiologically active product and so contact should be minimised, especially if the user is taking a form of medication, as interactions can sometimes give unexpected and undesired results. POTENTIAL HEALTH EFFECTS INHALATION: SHORT TERM EXPOSURE: Available data indicates that this prod Leia o documento completo